FDA
approval
· 2020-01-27
FDA Approved: DICLOFENAC SODIUM — Original Application (BluePoint Laboratories)
Summary
FDA approved diclofenac sodium topical gel, 1%, under an Original Application (ANDA) by BluePoint Laboratories for relief of osteoarthritis pain in joints.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM TOPICAL GEL, 1%)